Of all the patients, 25 had non-small cell lung cancer (NSCLC) and 10 had epidermal growth factor receptor (EGFR) or Anaplastic Lymphoma Kinase (ALK) mutations. Here, EGFR is linked to non-small cell lung carcinoma.